# Gastric Cancer RAD001 Study

> **NCT01514110** · PHASE1,PHASE2 · COMPLETED · sponsor: **Chinese University of Hong Kong** · enrollment: 35 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** RAD001

## Key facts

- **NCT ID:** NCT01514110
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01-23
- **Primary completion:** 2019-03-06
- **Final completion:** 2019-03-06
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2019-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01514110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01514110, "Gastric Cancer RAD001 Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01514110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*